Heparin-binding Epidermal Growth Factor-like Growth Factor is an Autocrine Growth Factor for Human Keratinocytes
Overview
Authors
Affiliations
Since heparin-binding epidermal growth factor (HB-EGF) is a member of the EGF family and binds to EGF receptor, we tested recombinant HB-EGF for its ability to stimulate human keratinocyte proliferation. The effect of HB-EGF on human keratinocytes was dependent on the cell density. HB-EGF optimally increased the cell number by 1.8-fold at 1.0 ng/ml for a 4-day incubation period under subconfluent culture. In contrast, under confluent culture, 10 ng/ml HB-EGF optimally increased the DNA synthesis 2.1-fold. To examine the production of HB-EGF by human keratinocytes, the analysis of human keratinocyte-conditioned medium was undertaken by a combination of heparin affinity column chromatography, EGF receptor-stimulating assay, immunoblotting, and neutralization. Heparin column chromatography fractionated three activities, peaks 1, 2, and 3, which contained immunoreactive 30- and 27-, 19-, and 14.5-kDa bands, respectively. The anti-HB-EGF-blocking antibody neutralized the activities of peaks 2 and 3 by 38 and 22%, respectively, but did not neutralize the activity of peak 1 at all. The antibody reduced the cell growth by 37% for a 4-day incubation period. Northern blot analysis detected a 2.5-kilobase transcript of HB-EGF. The addition of 1 ng/ml HB-EGF optimally increased the levels of HB-EGF mRNA 5.4-fold at 1 h and TGF-alpha mRNA 3.1-fold at 3 h. Interestingly, the addition of TGF-alpha at 1 ng/ml to keratinocyte cultures enhanced the level of HB-EGF mRNA 10.2-fold at 6 h. 1 ng/ml EGF also increased HB-EGF mRNA levels 10.9-fold at 1 h. These results suggest that HB-EGF is an autocrine growth factor for human keratinocytes, and HB-EGF and TGF-alpha act not only by an autoinductive mechanism but also by mutual amplification.
Biological processes and factors involved in soft and hard tissue healing.
Bartold M, Ivanovski S Periodontol 2000. 2024; 97(1):16-42.
PMID: 38243683 PMC: 11808446. DOI: 10.1111/prd.12546.
Kwack M, Hamida O, Kim M, Kim M, Sung Y Sci Rep. 2023; 13(1):21421.
PMID: 38049592 PMC: 10696020. DOI: 10.1038/s41598-023-48942-4.
Won K, Lee R, Choi S, Kim J, Hwang S, Nah S Int J Mol Sci. 2023; 24(18).
PMID: 37762395 PMC: 10531430. DOI: 10.3390/ijms241814094.
ErbBs in Lens Cell Fibrosis and Secondary Cataract.
VanSlyke J, Boswell B, Musil L Invest Ophthalmol Vis Sci. 2023; 64(10):6.
PMID: 37418274 PMC: 10337807. DOI: 10.1167/iovs.64.10.6.
Therapeutic role of growth factors in treating diabetic wound.
Zheng S, Wan X, Kambey P, Luo Y, Hu X, Liu Y World J Diabetes. 2023; 14(4):364-395.
PMID: 37122434 PMC: 10130901. DOI: 10.4239/wjd.v14.i4.364.